DEZHOU, China, April 29, 2025 /PRNewswire/ — A report from Dezhou Daily and Shandong Publicity:
The 2025 Shandong High-quality Cultural and Tourism Industry Development Conference was officially launched on the evening of April 24 in Dezhou, Shandong Province, China. Hosted by the Shandong Provincial Committee of the Chinese Communist Party (CPC) and the Shandong Provincial Government, the event was co-organized by the Shandong Provincial Department of Culture and Tourism and the CPC Dezhou Municipal Committee and Municipal Government. This year’s conference marked a significant milestone with its first international expansion, featuring concurrent sessions and promotional meetings in Singapore.
Themed “Hospitable Shandong, Virtue Across the World,” the conference focused on stimulating domestic travel demand and encouraging visitor spending, with the goal of creating a distinctive, innovative, and immersive cultural tourism experience. The event welcomed a distinguished roster of attendees, including Liu Shijun, Executive Director of the UN Tourism, Shi Zhongjun, Secretary-General of the ASEAN-China Centre, ambassadors stationed in China, senior officials from Shandong Province, and representatives from industry associations, businesses, and media outlets.
To boost inbound tourism, Shandong Province is introducing a comprehensive package of initiatives, including enhanced policy support, expanded international partnerships, and targeted overseas marketing strategies. The province is pursuing expedited one-hour customs clearance for inbound travelers, enabling 24-hour international transit without inspection, and broadening its global connectivity with the launch of eight new international air routes and the annual sailing of 30 international cruises.
ข่าวที่เกี่ยวข้อง
- Xinhua Silk Road: Jing’an District promotes investment opportunities, global business cooperation at 2026 CIIE
- Binance Blockchain Week Bangkok 2026 Unveils First Wave of Speakers, Spotlighting the Convergence of Traditional Finance and Digital Assets
- Ascletis Submits IND Application to the U.S. FDA for ASC30_39 FDC, a Potentially First-in-Class Oral Small Molecule Fixed-Dose Combination of GLP-1R Agonist and Selective Amylin Receptor Agonist, for the Treatment of Obesity
- Ali Y. Koç: ‘The Energy Transition Has Become the Cornerstone of Competitiveness in Industry’
